Bile Acids: A Novel Multiple Sclerosis Therapy?
Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are...
Long-term HSCT Outcomes in Norway
Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a...
‘Wearing Off’ Of MS Treatments Between Doses
Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major...
Retinoic Acid and Calcitriol May Promote Remyelination
Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell...
BTK Inhibitors in the Treatment of MS
What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B...
Neural Stem Cell Transplantation for Progressive MS
Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of...
Treating Fatigue in Multiple Sclerosis
Fatigue. It is one of the most commonly reported symptoms by people living with multiple sclerosis (MS). Not only do many people experience it,...
mRNA Vaccines & Their Potential in MS
Recently published research from the University Medical Center of the Johannes Gutenberg University has looked at the use of an mRNA vaccine as a...
MS Research in the New Millennium: 2000 – 2020
It’s been 20 years since the world nervously welcomed the new millennium. Let’s look back on those two decades and examine the major...
Research Reflections: Siponimod Trial Results
In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod)....